CDC advises docs to prescribe Tamiflu, Relenza to fight flu

Share this article:
The Centers for Disease Control and Prevention (CDC) is asking doctors not to prescribe two common generic antivirals, amantadine and rimantidine, during the 2005-2006 flu season because recent lab tests showed this winter's predominant flu strain is resistant to the drugs. The CDC has tested 120 influenza A (H3N2) virus isolates and found that 91% were resistant to amantadine and rimantadine. This represents a sharp increase from last year when only 11 percent of isolates tested were resistant and 1.9 percent were resistant the year before that. “This is certainly unexpected news as we now have to remove a few tools from our tool box that we use to combat influenza,” said Julie Gerberding, CDC director. The CDC is recommending Roche’s Tamiflu (oseltamivir) and GlaxoSmithKline’s Relenza (zanamivir) be prescribed if an antiviral medication is needed for the treatment or prevention of influenza.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.